Skip to main content

Cancers

Cancers is published by Multidisciplinary Digital Publishing Institute. This page lists its abbreviations and what the registries record about it. It also shows how to cite one of its articles in 12 styles.

What the registries record

Cancers is listed under the ISSN 2072-6694.

What the registries record
FactRecordSource
PublisherMultidisciplinary Digital Publishing InstituteOpenAlex
Open accessOpen access, per OpenAlexOpenAlex
Listed in DOAJNot listed in DOAJ, per OpenAlexOpenAlex
Article processing charge$3,499 per articleOpenAlex
2-year mean citedness6.13OpenAlex
h-index241OpenAlex
Indexed in MEDLINENot listed as indexed in MEDLINE, per NLMNLM
NLM abbreviationCancers (Basel)NLM
ISO 4 abbreviationCancersLTWA

The Journal Impact Factor is Clarivate's figure, and this page does not show it.

This page records facts and never judges a journal. A journal missing from an index can still be sound.

The figures are a snapshot taken on 2026-11-19, so a registry may have changed since.

Abbreviations

NLM gives "Cancers (Basel)" and ISO 4 gives "Cancers". A style that shortens journal names may use its own list, so a reference on this page can differ from the forms above.

How to cite an article from Cancers

The sample is one article of the journal. Its title is "Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study". Its DOI is 10.3390/cancers11081084. CiteTools wrote each reference from the Crossref record.

APA Style

Kudo, M., Ueshima, K., Chan, S., Minami, T., Chishina, H., Aoki, T., Takita, M., Hagiwara, S., Minami, Y., Ida, H., Takenaka, M., Sakurai, T., Watanabe, T., Morita, M., Ogawa, C., Wada, Y., Ikeda, M., Ishii, H., Izumi, N., & Nishida, N. (2019). Lenvatinib as an initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and Child–Pugh A liver function: A proof-of-concept study. Cancers, 11(8), Article 1084. https://doi.org/10.3390/cancers11081084

MLA Style

Kudo, Masatoshi, et al. “Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-to-Seven Criteria and Child–Pugh A Liver Function: A Proof-of-Concept Study.” Cancers, vol. 11, no. 8, July 2019, 1084, https://doi.org/10.3390/cancers11081084.

Chicago Style

Kudo, Masatoshi, Kazuomi Ueshima, Stephan Chan, et al. “Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-to-Seven Criteria and Child–Pugh A Liver Function: A Proof-of-Concept Study.” Cancers 11, no. 8 (2019): 1084. https://doi.org/10.3390/cancers11081084.

Harvard Referencing

Kudo, M. et al. (2019) ‘Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-to-Seven Criteria and Child–Pugh A Liver Function: A Proof-of-Concept Study’, Cancers, 11(8), 1084. Available at: https://doi.org/10.3390/cancers11081084.

IEEE Style

M. Kudo et al., “Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-to-Seven Criteria and Child–Pugh A Liver Function: A Proof-of-Concept Study,” Cancers, vol. 11, no. 8, Art. no. 1084, Jul. 2019, doi: 10.3390/cancers11081084.

Vancouver Style

Kudo M, Ueshima K, Chan S, Minami T, Chishina H, Aoki T, et al. Lenvatinib as an initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and Child–Pugh A liver function: a proof-of-concept study. Cancers (Basel). 2019 Jul 31;11(8):1084. doi:10.3390/cancers11081084.

AMA Style

Kudo M, Ueshima K, Chan S, et al. Lenvatinib as an initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and Child–Pugh A liver function: a proof-of-concept study. Cancers (Basel). 2019;11(8):1084. doi:10.3390/cancers11081084

ACS Style

Kudo, M.; Ueshima, K.; Chan, S.; Minami, T.; Chishina, H.; Aoki, T.; Takita, M.; Hagiwara, S.; Minami, Y.; Ida, H.; Takenaka, M.; Sakurai, T.; Watanabe, T.; Morita, M.; Ogawa, C.; Wada, Y.; Ikeda, M.; Ishii, H.; Izumi, N.; Nishida, N. Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-to-Seven Criteria and Child–Pugh A Liver Function: A Proof-of-Concept Study. Cancers 2019, 11 (8), 1084. DOI: 10.3390/cancers11081084

CSE Style

Kudo M et al. 2019. Lenvatinib as an initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and Child–Pugh A liver function: a proof-of-concept study. Cancers. 11(8):1084. https://doi.org/10.3390/cancers11081084

ASA Style

Kudo, Masatoshi, Kazuomi Ueshima, Stephan Chan, Tomohiro Minami, Hirokazu Chishina, Tomoko Aoki, Masahiro Takita, Satoru Hagiwara, Yasunori Minami, Hiroshi Ida, Mamoru Takenaka, Toshiharu Sakurai, Tomohiro Watanabe, Masahiro Morita, Chikara Ogawa, Yoshiyuki Wada, Masafumi Ikeda, Hiroshi Ishii, Namiki Izumi, and Naoshi Nishida. 2019. “Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-to-Seven Criteria and Child–Pugh A Liver Function: A Proof-of-Concept Study.” Cancers 11(8):1084. doi:10.3390/cancers11081084.

APSA Style

Kudo, Masatoshi, Kazuomi Ueshima, Stephan Chan, Tomohiro Minami, Hirokazu Chishina, Tomoko Aoki, Masahiro Takita, et al. 2019. “Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-to-Seven Criteria and Child–Pugh A Liver Function: A Proof-of-Concept Study.” Cancers 11 (8): 1084. doi: 10.3390/cancers11081084.

OSCOLA

Kudo M and others, ‘Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-to-Seven Criteria and Child–Pugh A Liver Function: A Proof-of-Concept Study’ (2019) 11 Cancers 1084 <https://doi.org/10.3390/cancers11081084>

Frequently asked questions

What is the abbreviation of Cancers?

NLM gives "Cancers (Basel)" and ISO 4 gives "Cancers". The ISO 4 form is written from the LTWA rules. A style that shortens journal names may use its own list, so a reference on this page can differ from the forms above.

How do I cite an article from Cancers?

Paste the DOI of the article into the CiteTools list and choose a style. The 12 references above show one article in every style.

Where do the facts on this page come from?

OpenAlex gives the publisher, access, DOAJ, charge, citedness and h-index figures. NLM gives MEDLINE indexing and its abbreviation. The LTWA rules give the ISO 4 form.

Related pages